August 22, 2022
Eyeing $1B in annual sales, Emergent BioSolutions to buy Narcan maker Adapt for $735M | Fierce Pharma
Emergent BioSolutions is mobilizing its M&A war chest again. Hard on the heels of its…
August 19, 2022
8 new high priority funding opportunities
We just released 8 new high priority funding opportunities where your company can make a…
August 19, 2022
Maryland’s RoosterBio and Seattle’s AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and…
August 19, 2022
Bio Tax Credit | Maryland Department of Commerce
The fiscal year 2022 program is now closed. The fiscal year 2023 program will begin…
August 19, 2022
Technical.ly: 2 new medtech startups will spin out of Johns Hopkins research fund grants
Two new medical startups, focusing on addressing vision loss and catheter-associated urinary tract infections (UTIs),…
August 16, 2022
521st Edition, August 16, 2022
Trouble Viewing This Email: Click Here August 16, 2022 FOUNDING MEMBER OF BHI…
